The Agence nationale de sécurité du médicament et des produits de santé shall transmit to the European Medicines Agency, for recording in the Community database, the certificates of good manufacturing practice that it issues.
Where an inspection reveals non-compliance with good manufacturing practice, this information is also transmitted for recording in the Community database.